AdvertisementMerck Immunotherapy Drug Shines In Lung Cancer StudyApril 16, 2018Richard HarrisfacebookEmailA combination of an immunotherapy drug from Merck and standard chemotherapy led to improved survival for cancer patients. (Getty Images)